The 2014 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: An update

Canadian Pharmacists Journal

Volumn 147, Issue 4, 2014, Pages 203-208

  Houle, Sherilyn K D ^a   Padwal, Raj ^a   Poirier, Luc ^a   Tsuyuki, Ross T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HEMOGLOBIN A1C;

BLOOD PRESSURE MONITORING; CANADIAN; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE MANAGEMENT; EDUCATION PROGRAM; GLUCOSE BLOOD LEVEL; HEALTH BEHAVIOR; HEART PERFUSION; HUMAN; HYPERTENSION; PHARMACIST; PRACTICE GUIDELINE; REVIEW; SODIUM INTAKE;

EID: 84907504085     PISSN: 17151635     EISSN: 1913701X     Source Type: Journal    
DOI: 10.1177/1715163514535341     Document Type: Review

References (22)

1. Hypertension Canada. Canadian Hypertension Education Program (CHEP)2014Recommendations. Available: www.hypertension.ca/en/chep (accessed April 7, 2014).
2. Chisholm-Burns MA,Kim Lee J,Spivey CA, et al.US pharmacists’ effect as team members on patient care: systematic review and meta-analyses.Med Care. 2010;48:923-33
3. Santschi V,Chiolero A,Burnand B, et al.Impact of pharmacist care in the management of cardiovascular disease risk factors: s systematic review and meta-analysis of randomized trials.Arch Intern Med. 2011;171:1441-53
4. Santschi V,Chiolero A,Paradis G, et al.Pharmacist interventions to improve cardiovascular disease risk factors in diabetes: a systematic review and meta-analysis of randomized controlled trials.Diabetes Care. 2012;35:2706-17
5. Houle SKD,Tsuyuki RT,Campbell NRC.The Canadian Hypertension Education Program (CHEP) 2011 guidelines for pharmacists.Can Pharm J (Ott). 2011;144:295-304
6. Houle SKD,Padwal R,Tsuyuki RT.The 2012-2013 Canadian Hypertension Education Program (CHEP) guidelines for pharmacists: an update.Can Pharm J (Ott). 2013;146:146-50
7. Beckett NS,Peters R,Fletcher AE, et al.for the HYVET study group. Treatment of hypertension in patients 80 years of age or older.N Engl J Med. 2008;358:1887-98
8. Lewington S,Clarke R,Qizilbash N, et al.Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.Lancet. 2002;360 (9349): 1903-13
9. D’Agostino RB,Belanger AJ,Kannel WB,Cruickshank JM.Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: the Framingham Study.BMJ. 1991;303:385
10. Cruickshank JM.Clinical importance of coronary perfusion pressure in the hypertensive patient with left ventricular hypertrophy.Cardiology. 1992;81:283-90
11. Messerli FH,Panjrath GS.The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?.J Am Coll Cardiol. 2009;54:1827-34
12. Rabkin SW,Waheed A,Poulter RS,Wood D.Myocardial perfusion pressure in patients with hypertension and coronary artery disease: implications for DBP targets in hypertension management.J Hypertens. 2013;31:975-82
13. He FJ,Li J,MacGregor GA.Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials.BMJ. 2013;346:f1325
14. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada.Can J Diabetes. 2013;37:S1-S212
15. Bennett CM,Guo M,Dharmage SC.HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review.Diabet Med. 2007;24:333-43
16. Hu Y,Liu W,Chen Y, et al.Combined use of fasting plasma glucose and glycated hemoglobin A1c in the screening of diabetes and impaired glucose tolerance.Acta Diabetol. 2010;47:231-6
17. Hansson L,Zanchetti A,Carruthers SG, et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial.Lancet. 1998;351:1755-62
18. Calonge N,Petitti DB,DeWitt TG,Gordis L.Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement.Ann Intern Med. 2009;150:396-404
19. Rothwell PM,Fowkes FG,Belch JF, et al.Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials.Lancet. 2011;377 (9759): 31-41
20. Vandvik PO,Lincoff AM,Gore JM, et al.Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Chest. 2012;141:e637S-e668S
21. McAlister FA,Wilkins K,Joffres M, et al.Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades.CMAJ. 2011;183:1007-13
22. Houle SKD,Campbell NRC,Tsuyuki RT.Home blood pressure monitoring plays a key role in hypertension management: review of applications, effectiveness and technique for pharmacists.Can Pharm J (Ott). 2011;141:18-20